BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32858752)

  • 1. Flash Glucose Monitoring Improves Glucose Control in People with Type 2 Diabetes Mellitus Receiving Anti-diabetic Drug Medication.
    Chen M; Li H; Shen Y; Liu B; Yan R; Sun X; Ye L; Lee KO; Ma J; Su X
    Exp Clin Endocrinol Diabetes; 2021 Dec; 129(12):857-863. PubMed ID: 32858752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Largest Amplitude of Glycemic Excursion Calculating from Self-Monitoring Blood Glucose Predicted the Episodes of Nocturnal Asymptomatic Hypoglycemia Detecting by Continuous Glucose Monitoring in Outpatients with Type 2 Diabetes.
    Wang S; Tan Z; Wu T; Shen Q; Huang P; Wang L; Liu W; Song H; Lin M; Shi X; Li X
    Front Endocrinol (Lausanne); 2022; 13():858912. PubMed ID: 35498416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
    Kasthuri S; Poongothai S; Anjana RM; Selvakumar J; Muthukumar S; Kayalvizhi S; Tariq S; Honey E; Gupta PK; Venkatesan U; Mohan V
    Diabetes Technol Ther; 2021 Mar; 23(3):213-220. PubMed ID: 32916063
    [No Abstract]   [Full Text] [Related]  

  • 7. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.
    Wada E; Onoue T; Kobayashi T; Handa T; Hayase A; Ito M; Furukawa M; Okuji T; Okada N; Iwama S; Sugiyama M; Tsunekawa T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Kuwatsuka Y; Ando M; Goto M; Arima H
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32518063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).
    Fokkert M; van Dijk P; Edens M; Barents E; Mollema J; Slingerland R; Gans R; Bilo H
    BMJ Open Diabetes Res Care; 2019; 7(1):e000809. PubMed ID: 31875133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
    Su JB; Wang XQ; Chen JF; Wu G; Jin Y
    Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care.
    Montero AR; Toro-Tobon D; Gann K; Nassar CM; Youssef GA; Magee MF
    BMC Endocr Disord; 2021 Nov; 21(1):222. PubMed ID: 34758807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Glycemic Improvement in Hemodialysis Patients Based on Time in Range, Assessed by Flash Glucose Monitoring.
    Hu K; Peng H; Ma Y; Li X; Bai R; Wang J; Xu J; Fu L; Liu J; Bai J; Wu H; Wang H; Jiang H
    Blood Purif; 2021; 50(6):883-890. PubMed ID: 33774625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
    Ajjan RA; Jackson N; Thomson SA
    Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy.
    Yan RN; Cai TT; Jiang LL; Jing T; Cai L; Xie XJ; Su XF; Xu L; He K; Cheng L; Cheng C; Liu BL; Hu Y; Ma JH
    Front Endocrinol (Lausanne); 2022; 13():832102. PubMed ID: 35222287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
    Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
    J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents.
    Abe H; Shikuma J; Suwanai H; Sano K; Okumura T; Kan K; Takahashi T; Miwa T; Suzuki R; Odawara M
    Geriatr Gerontol Int; 2019 Oct; 19(10):1030-1035. PubMed ID: 31486247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scans per day as predictors of optimal glycemic control in people with type 1 diabetes mellitus using flash glucose monitoring: what number of scans per day should raise a red flag?
    Sebastian-Valles F; Martínez-Alfonso J; Arranz Martin JA; Jiménez-Díaz J; Hernando Alday I; Navas-Moreno V; Armenta Joya T; Fandiño García MDM; Román Gómez GL; Lander Lobariñas LE; Martinez de Icaya P; Sampedro-Nuñez MA; Martínez-Vizacaíno V; Marazuela M
    Acta Diabetol; 2024 Mar; 61(3):343-350. PubMed ID: 37930420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes.
    Yaron M; Roitman E; Aharon-Hananel G; Landau Z; Ganz T; Yanuv I; Rozenberg A; Karp M; Ish-Shalom M; Singer J; Wainstein J; Raz I
    Diabetes Care; 2019 Jul; 42(7):1178-1184. PubMed ID: 31036546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
    Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
    J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
    Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.